251 related articles for article (PubMed ID: 35998020)
41. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.
Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES
Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924
[TBL] [Abstract][Full Text] [Related]
42. Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.
Misawa K; Imai A; Matsui H; Kanai A; Misawa Y; Mochizuki D; Mima M; Yamada S; Kurokawa T; Nakagawa T; Mineta H
Oncogene; 2020 Jun; 39(24):4741-4755. PubMed ID: 32415241
[TBL] [Abstract][Full Text] [Related]
43. Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking.
Cresswell GD; Nichol D; Spiteri I; Tari H; Zapata L; Heide T; Maley CC; Magnani L; Schiavon G; Ashworth A; Barry P; Sottoriva A
Nat Commun; 2020 Mar; 11(1):1446. PubMed ID: 32221288
[TBL] [Abstract][Full Text] [Related]
44. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
[TBL] [Abstract][Full Text] [Related]
45. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
[TBL] [Abstract][Full Text] [Related]
46. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
[TBL] [Abstract][Full Text] [Related]
47. Circulating cell-free tumor DNA analysis in pediatric cancers.
Andersson D; Fagman H; Dalin MG; Ståhlberg A
Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
[TBL] [Abstract][Full Text] [Related]
48. Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA.
Whalley C; Payne K; Domingo E; Blake A; Richman S; Brooks J; Batis N; Spruce R; ; Mehanna H; Nankivell P; Beggs AD
Epigenomes; 2021 Feb; 5(1):6. PubMed ID: 33777442
[TBL] [Abstract][Full Text] [Related]
49. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study.
Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E
Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443
[TBL] [Abstract][Full Text] [Related]
50. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
[TBL] [Abstract][Full Text] [Related]
51. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
52. Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data.
Chen S; Liu M; Zhou Y
Methods Mol Biol; 2018; 1754():67-95. PubMed ID: 29536438
[TBL] [Abstract][Full Text] [Related]
53. Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.
Chae YK; Davis AA; Jain S; Santa-Maria C; Flaum L; Beaubier N; Platanias LC; Gradishar W; Giles FJ; Cristofanilli M
Mol Cancer Ther; 2017 Jul; 16(7):1412-1420. PubMed ID: 28446639
[TBL] [Abstract][Full Text] [Related]
54. Review ctDNA and Breast Cancer.
Clatot F
Recent Results Cancer Res; 2020; 215():231-252. PubMed ID: 31605232
[TBL] [Abstract][Full Text] [Related]
55. Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.
Lee HW; Kim E; Cho KJ; Park HJ; Seo J; Lee H; Baek E; Choi JR; Han KH; Lee ST; Park JY
Liver Int; 2022 Oct; 42(10):2317-2326. PubMed ID: 35776657
[TBL] [Abstract][Full Text] [Related]
56. The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.
Jacob S; Davis AA; Gerratana L; Velimirovic M; Shah AN; Wehbe F; Katam N; Zhang Q; Flaum L; Siziopikou KP; Platanias LC; Gradishar WJ; Behdad A; Bardia A; Cristofanilli M
Clin Cancer Res; 2021 Mar; 27(5):1361-1370. PubMed ID: 33323406
[TBL] [Abstract][Full Text] [Related]
57. Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer.
Pellini B; Szymanski J; Chin RI; Jones PA; Chaudhuri AA
Thorac Surg Clin; 2020 May; 30(2):165-177. PubMed ID: 32327175
[TBL] [Abstract][Full Text] [Related]
58. Circulating tumour DNA for clinicians: current and future clinical applications.
Thompson MK; Gale D; Brenton JD
Clin Radiol; 2021 Oct; 76(10):737-747. PubMed ID: 34389159
[TBL] [Abstract][Full Text] [Related]
59. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning.
Liang N; Li B; Jia Z; Wang C; Wu P; Zheng T; Wang Y; Qiu F; Wu Y; Su J; Xu J; Xu F; Chu H; Fang S; Yang X; Wu C; Cao Z; Cao L; Bing Z; Liu H; Li L; Huang C; Qin Y; Cui Y; Han-Zhang H; Xiang J; Liu H; Guo X; Li S; Zhao H; Zhang Z
Nat Biomed Eng; 2021 Jun; 5(6):586-599. PubMed ID: 34131323
[TBL] [Abstract][Full Text] [Related]
60. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
Addanki S; Meas S; Sarli VN; Singh B; Lucci A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
